Platelets of Plaquenil, a drug containing chloroquine. (Illustration) - REX / SIPA

It is a mea culpa. While the debate goes on and about the study on hydroxychloroquine published by The Lancet, Dr. Mandeep R. Mehrale coordinator of the latter is expressed for the first time in an official statement that Le Parisien has was able to consult: "I did not do enough to ensure that the data source was appropriate. For that, and for all the disturbances - direct and indirect - I am truly sorry. "

This Thursday, he had asked the magazine to remove this article as his two other collaborators. Dr. Mandeep R. Mehrale therefore officially drops Dr. Sapan Desai, this entrepreneur with a troubled past who transmitted the huge database behind the study thanks to his company Surgisphere. "I no longer trust," he says. "We can no longer vouch for the veracity of the sources of primary data", this Friday wrote the three authors to the Lancet, questioning the refusal of the company having collected them, led by the fourth author, to give access to the database.

WHO announced the resumption of clinical trials with hydroxychloroquine

Published May 22 in  The Lancet, the study concluded that hydroxychloroquine is not beneficial to hospitalized Covid-19 patients and may even be harmful. Its publication had a worldwide impact and spectacular repercussions, pushing in particular the WHO (World Health Organization) to suspend clinical trials on hydroxychloroquine against Covid-19.

We know one who must rub his hands https://t.co/yJqmWP6fX7 #hydroxychloroquine

- 20 Minutes (@ 20Minutes) June 5, 2020

But finally, after many criticisms calling into question the methodology of the study, including on behalf of scientists skeptical on the interest of hydroxychloroquine in the treatment of Covid-19, the WHO announced Wednesday the resumption of clinical trials with this molecule.

Health

Coronavirus: Three of the four authors of the hydroxychloroquine study in "The Lancet" retract

World

Coronavirus: European study Discovery "plans" to resume testing on hydroxychloroquine

  • epidemic
  • Health
  • Controversy
  • Clinical test
  • study
  • Covid 19
  • Coronavirus